Before You Compare Skin Brightening OEM Quotes
KS Nutripharma manufactures skin brightening supplements as finished OEM / ODM / private-label SKUs for radiance, even-tone, antioxidant-beauty, photo-aging-support, and beauty-from-within programs. Quotes are comparable only after active architecture, specification, format, claim market, and annual volume are on the brief.
Buyer Snapshot
Procurement decision | What to define |
|---|---|
| Finished SKU | Skin-radiance / even-tone / antioxidant-beauty product under your brand |
| Active architecture | GSH-led, nicotinamide / vitamin C, polyphenol, carotenoid / lipid, photo-aging, collagen / barrier, or format-led gummy/stick |
| GSH specification | Required only if GSH is on the label — reduced-form assay and method, not “glutathione %” alone. See GSH quote trap |
| Format | Capsule, powder, stick, softgel, liquid, or gummy |
| Starting blueprint | Select from Formula 01–20 by architecture, format, and market. Common first quotes: Formula 02 (nicotinamide + vitamin C, GSH-free) or Formula 10 (GSH + nicotinamide) |
| MOQ | Typical starting ranges below — confirm on the brief |
| Timing | Indicative sample 7–15 days · commercial typically 30–45 days after formula, pack, and artwork lock |
| Documentation | Spec · COA · metals / micro · traceability · destination claim-language file list |
What to include in your RFQ: architecture or formula card · spec · format · destination market · daily serving · known prior defect.
Skin Brightening OEM Formula Architectures
Formulas 01–05 are the five primary commercial starting points. Formulas 06–20 cover delivery, ingredient, stack, format, and specialty requirements.
GSH is one architecture family within skin brightening OEM; other programs include nicotinamide/vitamin C, polyphenols, carotenoids, collagen/barrier, and format-led systems.
| Component | OEM starting range |
|---|---|
| Vitamin C (oral-use form) | 60–200 mg / serving |
| Nicotinamide | 50–150 mg / serving |
| Reduced GSH (optional) | 100–250 mg / serving if used |
| Gummy matrix | Gelatin or pectin |
| Format | Gummy |
Best fit: DTC / marketplace beauty gummy where sensory, format, and serving-size economics are prioritized.
Constraint: Process temperature · AW · flavor — stability.
| Component | OEM starting range |
|---|---|
| Nicotinamide | 100–250 mg |
| Vitamin C (oral-use form) | 100–200 mg |
| Optional grape seed or pomegranate extract | 50–100 mg |
| Optional reduced GSH | 100–250 mg |
| Flavor system | q.s. |
| Format | Stick · sachet |
Best fit: Single-serve DTC / e-commerce stick SKU.
Constraint: Stick moisture · film barrier · 30–60 day sensory retain — stability.
Architecture → formula → specification → format → destination market.
Choose the architecture first. Use 01–05 as primary starting points; 06–20 cover delivery, ingredient, stack, and format variants.
| Architecture | Primary start | Variants | Lock first | Main development risk |
|---|---|---|---|---|
| GSH-led | 01 capsule | 06 liposomal · 07 SAG · 08 powder/stick | Reduced-form assay + method | Oxidation / sulfur odor — stability |
| GSH + vitamin / nicotinamide | 10 (or 09 if vitamin C only) | 09 | Claim file + GSH assay | Fill / GSH retain / niacin rules |
| Nicotinamide / vitamin C (GSH-free) | 02 | 11 · 19 gummy · 20 stick | Destination claim language | Dose and claim file |
| Polyphenol / botanical | 03 | 12 · 13 | Extract assay and sensory | Extract variability / astringency |
| Carotenoid / lipid | 04 softgel | 14 · 15 | Oil delivery · natural vs synthetic source | Oxidation / color. Not a sunscreen |
| Photo-aging-support project | Quote after claim/license review | 16 · 17 | Claim file · branded-extract license | License, dual-pack MOQ if Formula 17 |
| Collagen / barrier / hydration | 05 drink | 18 capsule | Serving mass · 30–60 day sensory retain | Format mass / lipid vs powder |
| Gummy / stick | 19 · 20 | Nicotinamide + vitamin C architecture | Heat, water activity, sensory | Process heat often caps GSH load |
Positioning uses radiance, even-tone, antioxidant-beauty, photo-aging support, or beauty-from-within language scoped to the destination market. Do not use whitening, bleaching, skin lightening, pigment removal, or internal-sunscreen claims.
Barrier, hydration, and healthy-aging layers: active systems. Topical actives (kojic acid, arbutin, tranexamic acid, glabridin, azelaic acid) are outside this oral OEM scope.
Claims are part of the SKU specification
The same active system may require a different formula, dose, labeling set, and documentation pack depending on the destination market. Ingredient ≠ claim ≠ finished-product specification. Qualify claims against ingredient → dose → evidence → product category → destination market. Full split: QC, COA, and claims.
| Channel | Quote is judged on |
|---|---|
| Amazon / e-commerce | Appearance after storage · pack survival in fulfillment |
| DTC beauty | Sensory and appearance on repeat purchase |
| Practitioner / pharmacy | Assay method and lot-to-lot retain match |
| Private-label retail | Claim-language pack · supply continuity · MOQ steps |
GSH-free starts: Formula 02, 03, 11–13.
Before comparing price, lock four fields: form → analyte → assay method → acceptance range. Then verify the packed SKU (assay + appearance + odor). Reduced GSH, total glutathione, and glutathione by titration are not equivalent specifications. Purity does not replace reduced-form verification. Liposomal is a delivery specification, not a stand-alone absorption claim.
| Spec field | Lock | If skipped |
|---|---|---|
| Form / identity | Reduced GSH, SAG, liposomal GSH, or GSSG | Sample is GSH; launch lot is a different form |
| Analyte | Reduced GSH vs total glutathione | Two “98%” COAs describe different materials |
| Assay method | Validated method suitable for the claimed analyte | Quotes look aligned until the first QC dispute |
| Acceptance range | On spec and COA | No criterion for retain or launch lot |
| Form | Buy this when | Start from |
|---|---|---|
| Reduced L-glutathione (GSH) | Standard oral GSH SKU | Formula 01 (powder/stick = 08) |
| Oxidized glutathione (GSSG) | Only if the brief names GSSG | Not interchangeable with reduced GSH |
| S-acetyl glutathione (SAG) | Premium identity different from Formula 01 | Formula 07 |
| Liposomal glutathione | Delivery-system SKU | Formula 06 |
Formula 06 RFQ lock: phospholipid source · phospholipid:GSH ratio · particle size · PDI · encapsulation efficiency · GSH loading · oxidation stability · finished-product assay.
Finished-product assay and appearance can still change after sample approval. Define stability against the actual formula and pack — stability.
For custom briefs, specify the active layer first and map it to the required dosage form, specification, and claim market. Out of scope: kojic acid, arbutin, tranexamic acid, glabridin, azelaic acid.
| Active system | Typical components | Maps to |
|---|---|---|
| Radiance / even-tone | GSH, nicotinamide, vitamin C, selected botanicals | 01, 02, 10, 12, 13 |
| Polyphenol antioxidant | Grape seed, pine bark, pomegranate, green tea, resveratrol | 03 and variants. Generic pine bark ≠ branded Pycnogenol® |
| Carotenoid / lipid | Astaxanthin, lutein, lycopene, CoQ10, tocotrienols | 04, 14, 15. Lock natural vs synthetic source |
| Photo-aging-support project | Astaxanthin, Polypodium leucotomos, carotenoids | 16–17. License and claim file first |
| Barrier / hydration | Phytoceramides, HA, collagen peptides | 05, 18 |
| Redox / structural layers | NAC, cysteine, ALA, selenium, collagen, HA, ceramide | Support layers |
Delivery systems (specify on the RFQ): liposomal · microencapsulation · beadlets · oil-based / softgel · dual-pack. Absorption claims require product-specific evidence.
| Change | Usually affects |
|---|---|
| Add GSH | Oxidation · sulfur odor · reduced-form assay — stability |
| Add nicotinamide | Destination vitamin/niacin rules · claim file |
| Add vitamin C | Moisture · assay · pH · oral-use form only |
| Add carotenoids / CoQ10 / tocotrienols | Oil phase · color · softgel or dual pack · natural vs synthetic source |
| Add collagen | Serving mass · powder/stick format · odor |
| Add HA / phytoceramide | Serving mass · lipid vs powder split · allergen if wheat ceramides |
| Add Polypodium or branded botanical | License · claim file · extract continuity |
| Switch to gummy / stick / liquid | Heat · AW · mask · often lower GSH load |
| Switch to liposomal GSH | Delivery spec lock (Formula 06) |
Finished-product performance must be evaluated under filling, storage, freight, and destination climate. Format sets the dominant failure mode.
| Failure | Likely cause | Engineering response |
|---|---|---|
| GSH yellowing | Oxygen · humidity · metal ions · heat | Reduced-form retain · low-oxygen fill where scoped · barrier pack |
| Sulfur odor after storage | Volatile sulfur · weak mask · permeable pack · heat | Incoming odor retain · mask architecture · odor check after fill and accelerated hold |
| Powder / stick caking | Moisture · water activity · weak film | Lower AW · foil or equivalent · desiccant as scoped · humidity trial |
| Carotenoid color drift | Oxygen · UV · powder vs oil format | Softgel or protected beadlet · opaque / amber pack |
| Gummy heat / AW failure | Process heat · AW drift · moisture migration | Seasonal freight rules · AW and matrix lock · cap GSH load |
| Liquid oxidation / darkening | Oxygen · pH · preservative mismatch | Closed process · nitrogen where scoped · light barrier |
State the prior defect and pack type on the RFQ. Typical monitoring targets (project-scoped): reduced-GSH retention on retain; appearance and odor; water-activity check; sensory retain after accelerated hold.
→ Hard capsules · Powders · Softgels · Gummies · Liquids · Moisture / stability · Stick-pack engineering
A blend that assays in the lab may still oxidize during transfer, bridge in hoppers, or pick up odor after filling. Pilot filling verifies blend flow, oxygen/moisture exposure, fill-weight consistency, and packaging compatibility.
| Scale | Typical issues |
|---|---|
| Pilot | Odor after filling · color shift · stick-seal contamination · gummy heat loss · hopper bridging |
| First commercial lots | Headspace oxidation · humidity caking · flavor drift · dual-pack mismatch |
| Repeat / industrial volume | Lot odor/color drift · carotenoid grade shift · pack-material shortage · aged inventory |
Sequence: technical definition → prototype → pack and humidity / transport check → GMP production after formula and artwork lock.
These are KS Nutripharma’s typical starting ranges, not fixed commercial terms and not industry-standard MOQs. Actual MOQ and timing depend on formula complexity, packaging configuration, ingredient procurement, testing scope, and production scheduling. Formula 17 (dual pack) is two production systems, two packs, and two stability files.
| Format | Typical starting MOQ |
|---|---|
| Capsules | 3,000–5,000 units / SKU |
| Gummies | 5,000–10,000 units / SKU |
| Powder / sachets / sticks | 1,000–3,000 units / SKU |
| Liquid / shots / RTD | Project-dependent |
| Dual pack (capsule + softgel) | Project-dependent — two components, two MOQs |
| Stage | Indicative timing after formula, pack, and artwork lock |
|---|---|
| Sample | 7–15 days |
| Pilot | 15–25 days |
| Commercial production | Typically 30–45 days |
Liquids, gummies, and effervescents often need a longer pack-compatibility hold than a GSH capsule.
An available lot does not establish year-round supply. Lock on the RFQ: raw-material continuity; alternate source on the same spec and sensory retain if GSH or a botanical is critical; safety stock versus make-to-order; packaging-material lead time; annual volume; destination climate.
Change control. Notice before ship if GSH form, assay method, flavor mask, botanical extract, or pack film changes.
A batch can pass identity, assay, microbiological and heavy-metal testing and still require a claim revision before listing in the destination market. Qualify claims against:
ingredient → dose → evidence → product category → destination market
Unsupported “whitening,” “bleaching,” “skin lightening,” “pigment removal,” or “internal sunscreen” language is a listing risk even when the COA passes. Prefer destination-scoped radiance, even-tone support, antioxidant beauty, or photo-aging support.
| Risk | What to require |
|---|---|
| Heavy metals | Pb · Cd · As · Hg as scoped — botanicals, marine antioxidants, algae-derived carotenoids |
| Micro | Incoming + finished-goods panel |
| Identity / assay | Method on the COA for each claimed active (GSH reduced-form if GSH is labeled) |
| Sensory retain | Color and odor retain for GSH and flavored SKUs |
| Traceability | Lot file: identity, QC release, retain, shipment |
| Claim file | Destination-allowed radiance / antioxidant / photo-aging-support language |
| Project stage | Typical documentation |
|---|---|
| Raw material approval | Specification · supplier COA · identity / assay requirements |
| Formula development | Formula sheet · ingredient specifications · development notes |
| Pilot | Batch record · in-process checks · fill / weight / sensory observations |
| Finished product | Finished-product COA · micro / metals as scoped · retain |
| Stability | Protocol and results where included in the project scope |
| Shipment | Batch traceability · packing records · export documents as required |
Docs pack (project-scoped): spec · COA · metals / micro · traceability · Halal / Kosher if in scope · destination export and claim-language file list. Typical markets: North America · Europe · Southeast Asia · Middle East · cross-border e-commerce.
Applicable systems include cGMP, ISO 22000, ISO 9001, HACCP, FSSC 22000, Halal and Kosher, subject to product, facility, and market scope.
After launch. Complaint assessment starts after lot code, pack photos, storage conditions, and batch information are received. CAPA follows whatever the retain supports.
Formula confidentiality. NDA · client-coded formulas · restricted document access.
Send this checklist — get a comparable skin brightening OEM quote
An incomplete RFQ produces a non-comparable quote.
- Which architecture and which primary formula (01–05) or variant (06–20), or “not specified — please recommend”?
- If GSH is on the label: form + reduced-GSH assay and method — or “not specified, please recommend”?
- Target daily serving (mg or g of each active, not only “1 capsule”)?
- Capsule, powder, stick, softgel, liquid, gummy — stability-first or format-first?
- Destination export market and channel (Amazon, DTC, retail, practitioner)?
- Claim file: radiance / even-tone / antioxidant / photo-aging support — and which words the market forbids?
- Required certifications (Halal / Kosher / vegan HPMC only where source, process, and cert scope allow)?
- Required COA fields and whether stability is in scope?
- Annual volume and destination climate?
- Shelf-life target and known prior defect?
- Add-ons (ceramide, HA, CoQ10, resveratrol, EGCG, Polypodium, carnosine, etc.)?
Primary: Send Your SKU Brief
Secondary: Get a Comparable Quote
Technical: Request Formula + Spec Options · Request COA / QC Documentation
Selected references for ingredient evidence and regulatory context. Manufacturing specifications, stability acceptance criteria, and QC requirements are project-specific and are established through the applicable product specification and testing plan. These sources do not document KS Nutripharma manufacturing capability.
- U.S. Food and Drug Administration. Dietary supplements and structure/function claim framework (21 CFR 101.93). FDA dietary supplements
- NIH Office of Dietary Supplements. Vitamin C — Health Professional Fact Sheet. ods.od.nih.gov
- NIH Office of Dietary Supplements. Niacin — Health Professional Fact Sheet (includes nicotinamide). ods.od.nih.gov
- European Commission. Nutrition and health claims under Regulation (EC) No 1924/2006. EC health claims
- Minich DM, Brown BI. A review of dietary (phyto)nutrients for glutathione support. Nutrients. 2019;11(9):2073. Oral glutathione status evidence is mixed and formulation-dependent. PMC6770193
- Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9):827–833.
- NIH Office of Dietary Supplements. Vitamin A and Carotenoids — Health Professional Fact Sheet. ods.od.nih.gov
- NIH Office of Dietary Supplements. Vitamin E — Health Professional Fact Sheet. ods.od.nih.gov
- Collagen peptides are specified as protein ingredients (species/source on the COA). Destination labeling follows protein/collagen identity rules; this page does not treat collagen as a radiance-efficacy citation.
- Palombo P, et al. Beneficial long-term effects of combined oral/topical antioxidant treatment with lutein and zeaxanthin on human skin. Skin Pharmacol Physiol. 2007;20(4):199–210. Carotenoid skin research is not a UV-block or internal-sunscreen claim.
- NIH Office of Dietary Supplements. Selenium — Health Professional Fact Sheet (upper-level context for redox-support formulas). ods.od.nih.gov
- Branded Polypodium leucotomos extracts: use the supplier’s specification, authorized-distributor status, and license file. Published photoprotection literature does not by itself authorize an “internal sunscreen” claim or a drop-in commercial blueprint.
